Home

Kate Haviland

CIK 1663022 · Chief Executive Officer · last filed 2026-07-02

Kate Haviland is a Chief Executive Officer who has filed 57 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for FULC, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$13.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

57

Lifetime Open-Market Net

-$13.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FULC Director — $3.75 — $0 8 2026-07-02
BCAX Director — $27.73 — $0 3 2026-06-10
AVLN Director — $34.56 — $0 1 2026-05-01
Blueprint Medicines Corp (BPMC) Delisted Chief Executive Officer 0 $129.46 $0 -$13.58M 43 2025-07-21

Recent Filings

57 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 FULC Grant (A) — $0 EDGAR
2026-06-10 BCAX Grant (A) — $0 EDGAR
2026-05-01 AVLN Grant (A) — $0 EDGAR
2025-07-21 Blueprint Medicines Corp (BPMC) Delisted Mixed −165,929 $0 EDGAR
2025-06-30 FULC Grant (A) — $0 EDGAR
2025-06-10 BCAX Grant (A) — $0 EDGAR
2025-04-03 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −2,498 -$216.5K EDGAR
2025-04-01 Blueprint Medicines Corp (BPMC) Delisted Notice (144) −2,498 -$221.1K EDGAR
2025-03-07 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −16,151 -$1.43M EDGAR
2025-03-04 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +35,200 $0 EDGAR
Showing 1–10 of 57
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.